Poster preview
ePoster
G3BP1 MAINTAINS LYSOSOMAL HOMEOSTASIS TO LIMIT TAU AGGREGATE ACCUMULATION
Yoshihisa Watanabeand 3 co-authors
Kyoto Prefectural University of Medicine
FENS Forum 2026 (2026)
Barcelona, Spain
Board PS07-10AM-170
Presentation
Date TBA
Board: PS07-10AM-170
Event Information
Poster Board
PS07-10AM-170
Poster
View posterAbstract
Tau aggregation is a pathological hallmark of a group of neurodegenerative diseases collectively termed tauopathies. While impaired proteostasis is known to drive the accumulation of abnormal proteins, the molecular factors influencing Tau aggregate clearance remain incompletely understood. In this study, we employed a cell-based Tau reporter assay combined with a lentivirus-based pooled CRISPR-Cas9 loss-of-function library to identify genes that regulate Tau aggregation. Genome-wide screening revealed that candidate genes were significantly enriched in categories related to mRNA metabolic processes and autophagy. Among them, we focused on the RNA-binding protein G3BP1, which is functionally associated with both processes. Detailed analyses showed that G3BP1 deficiency promoted the accumulation of Tau aggregates without affecting stress granule formation or autophagic flux. Instead, G3BP1 dysfunction resulted in impaired lysosomal homeostasis, as evidenced by reduced lysosomal abundance and acidification. Furthermore, lysosomal damage induced by LLOMe enhanced Tau aggregation, particularly in G3BP1-deficient cells. Conversely, pharmacological activation of TFEB by the curcumin analog C1 restored lysosomal function and suppressed Tau aggregate accumulation to wild-type levels. These findings highlight a role of G3BP1 in maintaining lysosomal homeostasis and promoting Tau clearance. Our results further suggest that therapeutic strategies aimed at enhancing lysosomal biogenesis, such as TFEB activation, may hold promise for the treatment of tauopathies.
Recommended posters
DISCOVERY OF NOVEL GENETIC MODULATORS OF TAU AGGREGATION IN ALZHEIMER’S DISEASE
Ho Yeong Ryoo, Sunyoung Park, Jong Ho Kim, Dong-Gyu Jo
DISTINCT TAU ISOFORMS DIFFERENTIALLY DISRUPT AUTOPHAGY AND MITOCHONDRIAL FUNCTION: IMPLICATIONS FOR TAUOPATHIES
Ariadna Sancha Velasco, Jorge Navarro-Nadal, Sofía Soria-Utrilla, José Jiménez-Villegas, Carolina Alquézar
GALECTIN-3 DEFICIENCY ATTENUATES DISEASE PROGRESSION IN PGRN-DEPENDENT FTD MICE
Marta García Cruzado, Jesús Soldán-Hidalgo, Lluís Camprubí-Ferrer, Beatriz Rojo, Maria-Stefania Tabara, Julia Monge, Juan García-Revilla, José Luis Venero, Tomas Deierborg, Antonio Boza-Serrano
MICROGLIAL ACTIVATION DRIVES TAU PATHOLOGY PROGRESSION IN ALZHEIMER’S DISEASE
Laura Trujillo-Estrada, Elba Lopez-Oliva, Mª Angeles Arredondo-Alcala, Juan Jose Fernandez-Valenzuela, Elisabeth Sanchez-Mejias, Vicente Roca-Agujetas, Clara Muñoz-Castro, Clara Garcia-Mayor, Marisa Vizuete, Javier Vitorica, Antonia Gutierrez
TAU CONTROLS THE HOMEOSTASIS OF SYNAPTIC NMDA RECEPTORS IN NEURONS
Xuan Ling Hilary Yong, Kristie Stefanoska, William C. Kwan, Isabelle Irons, Pranesh Padmanabhan, Evgeniia Samokhina, Andrew Kneynsberg, Nathalie Dehorter, Arne Ittner, Jürgen Götz, Victor Anggono
CORTICAL AND RETINAL TAUOPATHY ACROSS THE NEURODEVELOPMENT–NEURODEGENERATION CONTINUUM IN PRECLINICAL IPSC-DERIVED ORGANOID MODELS
Chiara D'Antoni, Federica Cordella, Lorenza Mautone, Paola Bezzi, Silvia Di Angelantonio